These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
249 related items for PubMed ID: 6231597
1. [Pharmacokinetics of azlocillin in chronic renal failure and hemodialysis patients]. Fillastre JP, Humbert G, Leroy A, Godin M. Presse Med; 1984 Mar 29; 13(13):797-801. PubMed ID: 6231597 [Abstract] [Full Text] [Related]
2. [Clinical pharmacokinetics of azlocillin]. Singlas E, Haegel C. Presse Med; 1984 Mar 29; 13(13):788-96. PubMed ID: 6231596 [Abstract] [Full Text] [Related]
3. Pharmacokinetics of azlocillin in subjects with normal and impaired renal function. Leroy A, Humbert G, Godin M, Fillastre JP. Antimicrob Agents Chemother; 1980 Mar 29; 17(3):344-9. PubMed ID: 7425600 [Abstract] [Full Text] [Related]
4. Intravenous azlocillin kinetics in patients on long-term hemodialysis. Aletta JM, Francke EF, Neu HC. Clin Pharmacol Ther; 1980 Apr 29; 27(4):563-6. PubMed ID: 7357815 [Abstract] [Full Text] [Related]
5. Azlocillin treatment of urinary tract infection in patients on haemodialysis. Hallan H, Svarva PL, Svartås TM, Widerøe T. Scand J Infect Dis Suppl; 1981 Apr 29; 29():55-8. PubMed ID: 6947406 [Abstract] [Full Text] [Related]
9. [Pharmacokinetics after discontinuous intravenous administration of azlocillin]. Naber K, Adam D. Arzneimittelforschung; 1983 Apr 29; 33(3):429-32. PubMed ID: 6683518 [Abstract] [Full Text] [Related]
10. Pharmacokinetics of azlocillin in children with cystic fibrosis. Bergan T, Michalsen H. Arzneimittelforschung; 1979 Apr 29; 29(12a):1955-7. PubMed ID: 543899 [Abstract] [Full Text] [Related]
12. Pharmacokinetics of temocillin (BRL 17421) in subjects with normal and impaired renal function. Leroy A, Humbert G, Fillastre JP, Borsa F, Godin M. J Antimicrob Chemother; 1983 Jul 29; 12(1):47-58. PubMed ID: 6619046 [Abstract] [Full Text] [Related]
13. [Pharmacokinetics of intramuscular mezlocillin in patients with normal and impaired renal function (author's transl)]. Brogard JM, Comte F, Kopferschmitt J, Dorner M, Lavillaureix. Nouv Presse Med; 1982 Feb 04; 11(5 Pt 2):340-6. PubMed ID: 6460973 [Abstract] [Full Text] [Related]
14. [Azlocillin--a new anti-pseudomonas penicillin. A review of the literature and pharmacokinetic studies]. Modr Z, Dvorácek K, Janků I, Krebs V. Infection; 1982 Feb 04; 10 Suppl 3():S184-90. PubMed ID: 7152688 [Abstract] [Full Text] [Related]
15. Pharmacokinetics of ornidazole in patients with renal insufficiency; influence of haemodialysis and peritoneal dialysis. Merdjan H, Baumelou A, Diquet B, Chick O, Singlas E. Br J Clin Pharmacol; 1985 Feb 04; 19(2):211-7. PubMed ID: 3986079 [Abstract] [Full Text] [Related]
16. [Pharmacokinetics of azlocillin in the burn patient]. Drugeon HB, Pannier M, Courtieu AL. Presse Med; 1984 Mar 29; 13(13):805-7. PubMed ID: 6231599 [Abstract] [Full Text] [Related]
17. Overview of acylureidopenicillin pharmacokinetics. Bergan T. Scand J Infect Dis Suppl; 1981 Mar 29; 29():33-48. PubMed ID: 7031864 [Abstract] [Full Text] [Related]